Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,351 total articles
ALKEF has already run hard in 2026, but price structure, neutral RSI, and sizable historical short interest paint a tactical buying opportunity. Enter at $1.19 with a stop at $0.95 and a target at $1.70 for a mid-term swing (45 trading days). Keep position size disciplined—this is a trade that leans on technicals and the potential for episodic shor…
Ford announced a reorganization after the departure of its high-profile EV chief. The market sold off modestly, but fundamentals - strong free cash flow, cheap valuation metrics, and execution levers in product and fleet channels - argue for a measured long trade. This idea outlines an entry, stop, target and the rationale behind a mid-term (45 tra…
Medtronic (MDT) looks like a constructive buy into any short-term weakness ahead of earnings. The company offers a 3.3% yield, steady free cash flow ($5.41B) and modest leverage (debt/equity ~0.57). Technically the stock is oversold relative to its 50-day trend and short interest is elevated enough to create a squeeze if results reassure investors.…
Sirius XM has ripped from its 52-week low to trade near $28 on a mix of short-covering, activist/stakeholder support and still-solid cash generation. The setup is buyable for a swing trade if you respect technical overbought conditions and use a tight stop. Valuation (P/E ~12, P/B ~0.79, FCF yield north of 12%) and a healthy $1.245B free cash flow …
Micron has moved from cyclical recovery to structural beneficiary of AI infrastructure buildout. Strong fundamentals - $10.3B free cash flow, ROE >33%, low leverage - plus continued supply constraints and positive industry signals make a controlled long position attractive. Entry at $485.00, stop $425.00, target $650.00 for a long-term trade (180 t…
Bank OZK (OZK) trades at a sub-1x P/B and under 8x P/E despite a 63-quarter dividend increase streak, healthy liquidity, and bullish technicals. We initiate a position for a 180-trading-day horizon with an entry at $48.50, a stop at $44.00 and a target of $60.00. Risk is real — concentration and credit cycles matter — but the market appears to unde…
Kraft Heinz is priced like a company with persistent deterioration, but its balance sheet, free cash flow and an outsized dividend create a high-reward asymmetric trade if management can merely stabilize revenue and margins. Enter a tactical long on weakness with tight risk control and a 45-trading-day horizon.
Carriage Services (CSV) is a cash-generative consolidator in funeral and cemetery services. At about $50, the stock trades at roughly 15x earnings with $40m in free cash flow and a high return on equity. I recommend a mid-term long: enter at $50.00, target $60.00, stop $45.00. Catalysts include an upcoming dividend, active M&A, and operational lead…
Alphabet enters its upcoming quarterly results with several binary reads: AI user growth and product monetization, Google Cloud contract cadence, ad demand vs. macro fatigue, and management guidance on AI spend. These four themes create a high-conviction, asymmetric trade setup. I lay out a mid-term (45 trading days) long trade with entry, stop and…
SELLAS Life Sciences (SLS) is a small-cap clinical-stage biotech that has drawn attention after encouraging early-stage immunotherapy and CDK9 data. The stock ($4.70) sits between its 52-week low ($1.29) and high ($6.14), with an elevated short-interest profile and heavy trading. Given an upcoming clinical inflection for its AML program and stretch…
Mercury Systems (MRCY) remains a buy for investors willing to tolerate execution risk. The company sits squarely in the defense electronics sweet spot—edge processing, secure storage and space-qualified recorders—and recent contract awards keep revenue visibility healthy. Valuation is premium at roughly $4.7B market cap but backed by positive free …
Nokia is moving from commoditized telecom vendor toward an AI-native network vendor thanks to strategic investments and partnerships (including NVIDIA and Orange), improving technical momentum, and a stretched recovery from last year’s lows. Market cap sits near $57.2B while the stock trades near its 52-week high; this trade targets a 36% upside ov…
Credo Technology is executing on a clear AI-data-center play: fast revenue growth, high gross margins, and an accretive silicon-photonics acquisition. Technical momentum and low days-to-cover amplify upside in the near-term. Trade plan included for a mid-term (45 trading days) strategy with defined entry, target, and stop.
<p>AT&T's broadband franchise is quietly stabilizing margins and free cash flow while the stock trades at a multi-year discount to fundamentals. With a current price near $26.58, a 4%+ yield and an EV/EBITDA of ~6.5, the risk/reward favors owning the name into near-term catalysts tied to FirstNet upgrades and broadband monetization. This trade idea…
TeraWulf has moved from pure bitcoin mining toward high-density AI/HPC colocation and GPU leasing. With a $900M equity raise to fund a Hawesville campus and an enterprise value near $11.6B, the stock offers asymmetric upside if management executes on leasable capacity and GPU demand while carrying material execution and capital risks.
ServiceNow plunged after an earnings beat and a cautious CFO comment about Middle East deal timing. Fundamentals remain intact: $3.77B in revenue for the quarter, $4.58B of trailing free cash flow, and a market cap under $90B after the selloff. This trade targets a recovery to $130 over the next 45 trading days, with a tight stop below the recent 5…
Micron’s recent rally feels more like short-covering and rotation than a durable fundamental turn. Memory markets remain cyclical and capacity additions plus shifting AI memory demand favor HBM and specialized modules over commodity DRAM. I outline a tactical short with a clear entry, stop and target for a mid-term window while calling out the cata…
Kinder Morgan (KMI) trades at $31.28 with a $70B market cap and $102.7B enterprise value. Stable contract cash flows, a $10B+ growth backlog and a 3.7% yield create a favorable risk-reward for a long trade targeting $40 over the next 180 trading days. Entry at $31.28, stop at $29.00, target $40.00.
CNX Resources is trading at depressed multiples despite generating roughly $534M in free cash flow and carrying moderate leverage. Management's conservative production stance, a growing RNG tax-credit stream, and a concentrated set of Utica completions set the stage for an earnings beat and multiple expansion. This trade targets a re-rating into th…
Toast turned profitable in 2025 and generated $608M of free cash flow. With roughly $16.9B market cap and an enterprise value that implies ~6x EV/ARR on 2026 guidance, the risk-reward favors a mid-term long while AI product adoption and enterprise expansion re-rate the multiple. Entry $28.00, target $36.00, stop $24.25; horizon mid term (45 trading…
Marvell is trading at fresh 52-week highs after a strategic photonics acquisition and expanding cloud appetite. Strong cash generation, solid ROE, and partnership momentum support a long trade. Valuation is rich but justified if growth sustains; manage risk around stretched technicals and execution.
Nebius is a neocloud infrastructure play that has converted large hyperscaler demand into multi-year contracted backlog. The setup offers asymmetric upside if the company executes on capacity builds and converts contracted revenue into realized billings. Valuation is aggressive today, so the trade leans on event-driven execution: buy into proof poi…
Brookfield Infrastructure (BIPC) owns power, data infrastructure and specialty energy assets that are directly exposed to the multi-year buildout of AI data centers and semiconductor fabs. The company is growing contracted capacity, delivering consecutive distribution increases and generating predictable cash flows. This trade idea outlines a long …
BridgeBio has moved from binary-event biotech to a commercial-stage rare-disease company. Strong long-term Attruby survival data, positive Phase 3 interim results for BBP-418, and a clear regulatory path for infigratinib give the stock asymmetric upside. I am upgrading to Buy with a defined entry at $73.10, a $93.00 target and a $60.00 stop loss on…
Domino's Pizza Group delivered a robust Q1 and now yields 5.65%, making it an attractive income-oriented long. The company's market position, franchise cash flow model and recent operational momentum support a trade that aims to capture dividend income plus capital appreciation while limiting downside with a tight stop.
